title: Endocannabinoid Mechanisms Influencing Nausea.
abstract: One of the first recognized medical uses of Δ(9)-tetrahydrocannabinol was treatment of chemotherapy-induced nausea and vomiting. Although vomiting is well controlled with the currently available non-cannabinoid antiemetics, nausea continues to be a distressing side effect of chemotherapy and other disorders. Indeed, when nausea becomes conditionally elicited by the cues associated with chemotherapy treatment, known as anticipatory nausea (AN), currently available antiemetics are largely ineffective. Considerable evidence demonstrates that the endocannabinoid system regulates nausea in humans and other animals. In this review, we describe recent evidence suggesting that cannabinoids and manipulations that enhance the functioning of the natural endocannabinoid system are promising treatments for both acute nausea and AN.
authors.affiliation: Department of Psychology, Collaborative Neuroscience Graduate Program, University of Guelph, Guelph, Ontario, Canada; Department of Physiology and Pharmacology, Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada.
authors.forename: Martin A
authors.initials: MA
authors.lastname: Sticht
authors.affiliation: Department of Psychology, Collaborative Neuroscience Graduate Program, University of Guelph, Guelph, Ontario, Canada.
authors.forename: Erin M
authors.initials: EM
authors.lastname: Rock
authors.affiliation: Department of Psychology, Collaborative Neuroscience Graduate Program, University of Guelph, Guelph, Ontario, Canada.
authors.forename: Cheryl L
authors.initials: CL
authors.lastname: Limebeer
authors.affiliation: Department of Psychology, Collaborative Neuroscience Graduate Program, University of Guelph, Guelph, Ontario, Canada. Electronic address: parkerl@uoguelph.ca.
authors.forename: Linda A
authors.initials: LA
authors.lastname: Parker
mesh_terms: D000818:Animals; D000932:Antiemetics; D000970:Antineoplastic Agents / Q000009:adverse effects; D003213:Conditioning, Psychological / Q000187:drug effects / Q000502:physiology; D063388:Endocannabinoids / Q000494:pharmacology / Q000502:physiology*; D006801:Humans; D009325:Nausea / Q000188:drug therapy / Q000503:physiopathology*
chemical_list: D000932:Antiemetics; D000970:Antineoplastic Agents; D063388:Endocannabinoids
keywords: 2-Arachidonoylglycerol; Acute nausea; Anandamide; Anticipatory nausea; CB1; Endocannabinoid; Gaping; Illness